Featured Headlines Feed for INSM Headlines for INSMED, INC. http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic 2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target http://www.fool.com/news/xt/trefis/www.trefis.com/stock/insm/articles/186733/2-biopharma-catalyst-trades-set-to-break-out-with-one-strong-acquisition-target/2013-05-15.aspx?source=itxwebtxt0000015 Trefis Wed, 15 May 2013 09:45:46 GMT 2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435081-2-biopharma-catalyst-trades-and-1-strong-acquisition-target-rumored-to-be-in-play.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 15 May 2013 08:31:00 GMT Benzinga's Top Initiations http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/05/3591379/benzingas-top-initiations.aspx?source=itxwebtxt0000015 Benzinga Wed, 15 May 2013 08:19:15 GMT Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed http://www.fool.com/news/xt/trefis/www.trefis.com/stock/insm/articles/186537/significant-near-term-top-line-data-catalyst-and-platform-technology-should-rally-insmed/2013-05-14.aspx?source=itxwebtxt0000015 Trefis Tue, 14 May 2013 10:39:21 GMT Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431661-significant-near-term-top-line-data-catalyst-and-platform-technology-should-propel-insmed.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 14 May 2013 10:01:00 GMT Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3586797/insmed-granted-key-composition-of-matter-patent-allowance-for-arikace-in-europe.aspx?source=itxwebtxt0000015 Benzinga Tue, 14 May 2013 08:11:51 GMT Insmed's CEO Discusses Q1 2013 Results - Earnings Call Transcript http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1412271-insmed-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 07 May 2013 22:41:05 GMT Quickly Approaching Biopharma Catalyst Events http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1363881-quickly-approaching-biopharma-catalyst-events.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 24 Apr 2013 08:30:00 GMT Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/215896/weekly-ceo-buys-highlight-ibtx-insm-gern-ino-equ.aspx?source=itxwebtxt0000015 GuruFocus Sun, 07 Apr 2013 19:34:49 GMT Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/weekly-ceo-buys-highlight-ibtx-insm-gern-ino-equ-cm234370.aspx?source=itxwebtxt0000015 Nasdaq Sun, 07 Apr 2013 18:06:27 GMT Orphan Status for Insmed's Arikace - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96329/orphan-status-for-insmeds-arikace.aspx?source=itxwebtxt0000015 Zacks Thu, 04 Apr 2013 16:15:01 GMT Arikace Receives Orphan Drug Designation For Treating Infections Caused By Non-Tuberculous Mycobacte http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3454351/arikace-receives-orphan-drug-designation-for-treating-infections-caused-by-non-tu.aspx?source=itxwebtxt0000015 Benzinga Thu, 28 Mar 2013 08:41:00 GMT UPDATE: Canaccord Genuity Initiates Insmed at Buy on New Treatment for Lung Infections http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3439272/update-canaccord-genuity-initiates-insmed-at-buy-on-new-.aspx?source=itxwebtxt0000015 Benzinga Fri, 22 Mar 2013 09:59:52 GMT Benzinga's Top Initiations http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/03/3438812/benzingas-top-initiations.aspx?source=itxwebtxt0000015 Benzinga Fri, 22 Mar 2013 07:23:47 GMT Insmed Loss Deepens in Q4, Narrows in 2012 http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/18/insmed-loss-deepens-in-q4-narrows-in/.aspx?source=itxwebtxt0000015 DailyFinance Mon, 18 Mar 2013 19:05:00 GMT Insmed Incorporated Management Discusses Q4 2012 Results - Earnings Call Transcript http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282841-insmed-incorporated-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015 Seeking Alpha Mon, 18 Mar 2013 10:50:09 GMT 5 Reasons to Worry About Next Week http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/5-reasons-to-worry-about-next-week-24/.aspx?source=itxwebtxt0000015 DailyFinance Fri, 15 Mar 2013 20:47:00 GMT Insmed Earnings: An Early Look http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/insmed-earnings-an-early-look/.aspx?source=itxwebtxt0000015 DailyFinance Fri, 15 Mar 2013 17:30:00 GMT Benzinga's Top Initiations http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/03/3403722/benzingas-top-initiations.aspx?source=itxwebtxt0000015 Benzinga Mon, 11 Mar 2013 07:40:23 GMT 8 Biotech Growth Names: Greg Wade http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1168181-8-biotech-growth-names-greg-wade.aspx?source=itxwebtxt0000015 Seeking Alpha Fri, 08 Feb 2013 12:50:44 GMT